GDF11 enhances therapeutic efficacy of mesenchymal stem cells for myocardial infarction via YME1L‐mediated OPA1 processing

Growth differentiation factor 11 (GDF11) has been shown to promote stem cell activity, but little is known about the effect of GDF11 on viability and therapeutic efficacy of cardiac mesenchymal stem cells (MSCs) for cardiac injury. To understand the roles of GDF11 in MSCs, mouse heart‐derived MSCs w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yun, Zhu, Jinyun, Zhang, Ning, Liu, Qi, Wang, Yingchao, Hu, Xinyang, Chen, Jinghai, Zhu, Wei, Yu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Tissue‐specific Progenitor and Stem Cells
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519765/
https://www.ncbi.nlm.nih.gov/pubmed/32515551
http://dx.doi.org/10.1002/sctm.20-0005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519765/
https://www.ncbi.nlm.nih.gov/pubmed/32515551
http://dx.doi.org/10.1002/sctm.20-0005

Ejemplares similares